The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 09, 2016

Filed:

Apr. 16, 2012
Applicants:

Amir Toporik, Holon, IL;

Amit Novik, Binyamina, IL;

Ronen Shemesh, Modiin, IL;

Inventors:

Amir Toporik, Holon, IL;

Amit Novik, Binyamina, IL;

Ronen Shemesh, Modiin, IL;

Assignee:

COMPUGEN LTD, Holon, IL;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 39/001 (2013.01); A61K 39/0008 (2013.01); A61K 39/0011 (2013.01); A61K 39/39 (2013.01); A61K 39/3955 (2013.01); C07K 14/70503 (2013.01); C07K 16/18 (2013.01); G01N 33/53 (2013.01); C07K 2319/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/43 (2013.01); C12N 2760/10022 (2013.01); C12N 2760/16121 (2013.01); C12N 2770/32031 (2013.01);
Abstract

This invention relates to LY6G6F, VSIG10, TMEM25 and LSR proteins, which are suitable targets for immunotherapy, treatment of cancer, infectious disorders, and/or immune related disorders, and drug development. This invention further relates to soluble LY6G6F, VSIG10, TMEM25 and LSR molecules, extracellular domains of LY6G6F, VSIG10, TMEM25 and LSR and conjugates, which are suitable drugs for immunotherapy, treatment of cancer, infectious disorders, and/or immune related disorders. This invention further relates to antibodies and antigen binding fragments and conjugates containing same, and/or alternative scaffolds, specific for LY6G6F, VSIG10, TMEM25 or LSR molecules, which are suitable drugs for immunotherapy, treatment of cancer, infectious disorders, and/or immune related disorders.


Find Patent Forward Citations

Loading…